• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于配体和结构的方法深入了解阿片类激动剂的亚型选择性。

Insights into subtype selectivity of opioid agonists by ligand-based and structure-based methods.

机构信息

Laboratory of Molecular Modeling & Design, School of Pharmacy, East China University of Science and Technology, 130 Meilong Road, Shanghai, 200237, China.

出版信息

J Mol Model. 2011 Mar;17(3):477-93. doi: 10.1007/s00894-010-0745-1. Epub 2010 May 25.

DOI:10.1007/s00894-010-0745-1
PMID:20499259
Abstract

To probe the selective mechanism of agonists binding to three opioid receptor subtypes, ligand-based and receptor-based methods were implemented together and subtype characteristics of opioid agonists were clearly described. Three pharmacophore models of opioid agonists were generated by the Catalyst/HypoGen program. The best pharmacophore models for μ, δ and κ agonists contained four, five and five features, respectively. Meanwhile, the three-dimensional structures of three receptor subtypes were modeled on the basis of the crystal structure of β2-adrenergic receptor, and molecular docking was conducted further. According to these pharmacophore models and docking results, the similarities and differences among agonists of three subtypes were identified. μ or δ agonists, for example, could form one hydrogen bond separately with Tyr129 and Tyr150 at TMIII, whereas κ ones formed a π-π interaction in that place. These findings may be crucial for the development of novel selective analgesic drugs.

摘要

为探究激动剂与三种阿片受体亚型结合的选择性机制,本文采用基于配体和基于受体的方法,清晰地描述了阿片类激动剂的亚型特征。应用 Catalyst/HypoGen 程序生成了三种阿片类激动剂的药效基团模型。μ、δ和 κ 激动剂的最佳药效基团模型分别包含四个、五个和五个特征。同时,基于β2-肾上腺素能受体的晶体结构构建了三种受体亚型的三维结构,并进一步进行了分子对接。根据这些药效基团模型和对接结果,确定了三种亚型激动剂之间的相似性和差异性。例如,μ 或 δ 激动剂可分别与 TMIII 上的 Tyr129 和 Tyr150 形成一个氢键,而 κ 激动剂则在该位置形成π-π 相互作用。这些发现可能对新型选择性镇痛药的开发具有重要意义。

相似文献

1
Insights into subtype selectivity of opioid agonists by ligand-based and structure-based methods.基于配体和结构的方法深入了解阿片类激动剂的亚型选择性。
J Mol Model. 2011 Mar;17(3):477-93. doi: 10.1007/s00894-010-0745-1. Epub 2010 May 25.
2
Differentiation of delta, mu, and kappa opioid receptor agonists based on pharmacophore development and computed physicochemical properties.基于药效团开发和计算得到的物理化学性质对δ、μ和κ阿片受体激动剂进行区分
J Comput Aided Mol Des. 2001 Apr;15(4):297-307. doi: 10.1023/a:1011187320095.
3
3D-QSAR comparative molecular field analysis on opioid receptor antagonists: pooling data from different studies.阿片受体拮抗剂的3D-QSAR比较分子场分析:整合来自不同研究的数据
J Med Chem. 2005 Mar 10;48(5):1620-9. doi: 10.1021/jm049117e.
4
Chemical function-based pharmacophore development for novel, selective kappa opioid receptor agonists.基于化学功能的新型选择性κ阿片受体激动剂药效团开发
J Mol Graph Model. 2008 Sep;27(2):131-9. doi: 10.1016/j.jmgm.2008.03.007. Epub 2008 Mar 28.
5
Non-peptide opioid receptor ligands - recent advances. Part I - agonists.
Curr Med Chem. 2002 Sep;9(17):1567-89. doi: 10.2174/0929867023369394.
6
Identification, structure-activity relationships and molecular modeling of potent triamine and piperazine opioid ligands.强效三胺和哌嗪类阿片样物质配体的鉴定、构效关系及分子模拟
Bioorg Med Chem. 2009 Aug 1;17(15):5583-97. doi: 10.1016/j.bmc.2009.06.026. Epub 2009 Jun 21.
7
A three-dimensional model of the delta-opioid pharmacophore: comparative molecular modeling of peptide and nonpeptide ligands.δ-阿片类药物药效基团的三维模型:肽类和非肽类配体的比较分子建模
Biopolymers. 2000 Jun;53(7):565-80. doi: 10.1002/(SICI)1097-0282(200006)53:7<565::AID-BIP4>3.0.CO;2-5.
8
Homology modeling of opioid receptor-ligand complexes using experimental constraints.利用实验约束条件对阿片受体-配体复合物进行同源建模。
AAPS J. 2005 Oct 5;7(2):E434-48. doi: 10.1208/aapsj070243.
9
Molecular Docking, Molecular Dynamics, and Structure-Activity Relationship Explorations of 14-Oxygenated N-Methylmorphinan-6-ones as Potent μ-Opioid Receptor Agonists.14-氧化N-甲基吗啡喃-6-酮作为强效μ-阿片受体激动剂的分子对接、分子动力学及构效关系研究
ACS Chem Neurosci. 2017 Jun 21;8(6):1327-1337. doi: 10.1021/acschemneuro.6b00460. Epub 2017 Feb 9.
10
Molecular docking of opiates and opioid peptides, a tool for the design of selective agonists and antagonists, and for the investigation of atypical ligand-receptor interactions.阿片类药物和阿片肽的分子对接,一种用于设计选择性激动剂和拮抗剂的工具,以及用于研究非典型配体-受体相互作用。
Curr Med Chem. 2012;19(11):1587-601. doi: 10.2174/092986712799945030.

引用本文的文献

1
Molecular switches of the κ opioid receptor triggered by 6'-GNTI and 5'-GNTI.由6'-GNTI和5'-GNTI触发的κ阿片受体的分子开关
Sci Rep. 2016 Jan 8;6:18913. doi: 10.1038/srep18913.
2
In silico investigation of interactions between human cannabinoid receptor-1 and its antagonists.计算机模拟研究人类大麻素受体-1 与其拮抗剂的相互作用。
J Mol Model. 2012 Aug;18(8):3831-45. doi: 10.1007/s00894-012-1381-8. Epub 2012 Mar 9.
3
Consensus 3D model of μ-opioid receptor ligand efficacy based on a quantitative Conformationally Sampled Pharmacophore.

本文引用的文献

1
Opioid pharmacology.阿片类药物药理学
Pain Physician. 2008 Mar;11(2 Suppl):S133-53.
2
High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor.一种工程化人β2-肾上腺素能G蛋白偶联受体的高分辨率晶体结构
Science. 2007 Nov 23;318(5854):1258-65. doi: 10.1126/science.1150577. Epub 2007 Oct 25.
3
GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function.G蛋白偶联受体工程为β2肾上腺素能受体功能带来了高分辨率的结构见解。
基于定量构象采样药效团的 μ 阿片受体配体效力共识 3D 模型。
J Phys Chem B. 2011 Jun 9;115(22):7487-96. doi: 10.1021/jp202542g. Epub 2011 May 12.
Science. 2007 Nov 23;318(5854):1266-73. doi: 10.1126/science.1150609. Epub 2007 Oct 25.
4
Probes for narcotic receptor mediated phenomena. 34. Synthesis and structure-activity relationships of a potent mu-agonist delta-antagonist and an exceedingly potent antinociceptive in the enantiomeric C9-substituted 5-(3-hydroxyphenyl)-N-phenylethylmorphan series.用于麻醉受体介导现象的探针。34. 对映体C9取代的5-(3-羟基苯基)-N-苯基乙基吗啡系列中一种强效μ激动剂-δ拮抗剂及一种极其强效的抗伤害感受剂的合成与构效关系。
J Med Chem. 2007 Aug 9;50(16):3765-76. doi: 10.1021/jm061325e. Epub 2007 Jul 11.
5
4-Phenyl-4-[1H-imidazol-2-yl]-piperidine derivatives as non-peptidic selective delta-opioid agonists with potential anxiolytic/antidepressant properties. Part 2.4-苯基-4-[1H-咪唑-2-基]-哌啶衍生物作为具有潜在抗焦虑/抗抑郁特性的非肽类选择性δ-阿片受体激动剂。第2部分。
Bioorg Med Chem Lett. 2007 Jul 15;17(14):3860-3. doi: 10.1016/j.bmcl.2007.05.012. Epub 2007 May 10.
6
Synthesis and structure-activity relationships of 4-hydroxy-4-phenylpiperidines as nociceptin receptor ligands: Part 1.4-羟基-4-苯基哌啶作为孤啡肽受体配体的合成及构效关系:第1部分
Bioorg Med Chem Lett. 2007 Jun 1;17(11):3023-7. doi: 10.1016/j.bmcl.2007.03.061. Epub 2007 Mar 23.
7
Synthesis and structure-activity relationships of 4-hydroxy-4-phenylpiperidines as nociceptin receptor ligands: Part 2.
Bioorg Med Chem Lett. 2007 Jun 1;17(11):3028-33. doi: 10.1016/j.bmcl.2007.03.062. Epub 2007 Mar 21.
8
Novel malonamide derivatives as potent kappa opioid receptor agonists.
Bioorg Med Chem Lett. 2007 Apr 1;17(7):1951-5. doi: 10.1016/j.bmcl.2007.01.053. Epub 2007 Jan 25.
9
Synthesis and structure-activity relationships of N-substituted spiropiperidines as nociceptin receptor ligands.作为孤啡肽受体配体的N-取代螺哌啶的合成及其构效关系
Bioorg Med Chem Lett. 2007 Apr 15;17(8):2281-4. doi: 10.1016/j.bmcl.2007.01.069. Epub 2007 Jan 27.
10
A combined ligand-based and target-based drug design approach for G-protein coupled receptors: application to salvinorin A, a selective kappa opioid receptor agonist.一种用于G蛋白偶联受体的基于配体和基于靶点的联合药物设计方法:应用于选择性κ阿片受体激动剂Salvinorin A。
J Comput Aided Mol Des. 2006 Jul-Aug;20(7-8):471-93. doi: 10.1007/s10822-006-9067-x. Epub 2006 Sep 29.